Industrial Purity Specifications Methyl 1-(Mercaptomethyl)Cyclopropaneacetate

• GC Purity ≥98% ensures optimal Montelukast synthesis yields.
• Strict moisture control (0.02%) prevents thiol oxidation.
• Compliant with ICH guidelines for pharmaceutical intermediates.

In the pharmaceutical manufacturing sector, the quality of key intermediates dictates the success of the final active pharmaceutical ingredient (API) production. Methyl 1-(Mercaptomethyl)cyclopropaneacetate (CAS: 152922-73-1) serves as a critical building block in the synthesis of Montelukast, a widely prescribed leukotriene receptor antagonist. For process chemists and procurement managers, understanding the technical nuances of industrial purity is essential for maintaining reaction efficiency and regulatory compliance.

This compound, chemically known as 2-[1-(mercaptomethyl)cyclopropyl]acetic acid methyl ester, possesses a reactive thiol group and a strained cyclopropane ring. These functional groups require stringent control during production to prevent degradation. Sourcing materials that meet exacting specifications minimizes downstream purification costs and ensures consistent batch-to-batch performance in large-scale reactors.

GC Purity ≥98%: What It Means for Montelukast Intermediate Quality Control

Gas Chromatography (GC) analysis is the standard method for assessing the purity of volatile organic intermediates. A specification of ≥98% GC purity is not merely a number; it represents the threshold where impurity profiles remain manageable during subsequent coupling reactions. When the purity drops below this level, side reactions involving residual starting materials or isomers can significantly reduce the overall yield of the Montelukast synthesis.

High-purity grades reduce the burden on crystallization and distillation steps later in the manufacturing process. For buyers evaluating suppliers, requesting a detailed Certificate of Analysis (COA) is standard procedure. The COA should explicitly list the area percentage of the main peak alongside identified impurities. Consistency in this metric is vital for validating the synthesis route used by the supplier.

When sourcing high-purity Methyl 1-(Mercaptomethyl)cyclopropaneacetate, buyers should verify that the analytical method aligns with internal quality control protocols to avoid discrepancies in acceptance testing.

Technical Specifications Table

Parameter	Specification	Test Method
Chemical Name	Methyl 1-(Mercaptomethyl)cyclopropaneacetate	N/A
CAS Number	152922-73-1	N/A
Molecular Formula	C7H12O2S	N/A
Molecular Weight	160.24 g/mol	N/A
GC Purity	≥ 98.0%	GC-FID
Moisture Content	≤ 0.02%	Karl Fischer
Appearance	Colorless to Pale Yellow Liquid	Visual

Critical Impurity Profiles and Acceptance Criteria per ICH Guidelines

Pharmaceutical intermediates must adhere to strict impurity limits to ensure the safety of the final drug product. According to ICH Q3 guidelines, organic impurities above specific thresholds must be identified and qualified. For this cyclopropane derivative, common impurities may include unreacted precursors, over-alkylated byproducts, or oxidation products such as disulfides.

The thiol functionality is particularly susceptible to oxidation upon exposure to air or moisture. Therefore, the presence of the corresponding disulfide dimer is a critical quality attribute. Advanced suppliers utilize inert atmosphere packaging and nitrogen blanketing during the filling process to mitigate this risk. Procurement teams should prioritize vendors who demonstrate control over these specific degradation pathways.

Furthermore, residual solvents from the synthesis route must comply with ICH Q3C limits. Common solvents like toluene, methanol, or dichloromethane require rigorous removal via vacuum distillation. A robust quality system ensures that every batch released meets these international safety standards before shipment.

Role of Low Moisture Content (0.02%) in Reaction Consistency and Stability

Water content is a often overlooked parameter that can drastically impact reaction kinetics. In nucleophilic substitution reactions involving this ester, excess moisture can lead to hydrolysis of the ester group, forming the corresponding carboxylic acid. This side reaction consumes reagents and complicates workup procedures.

Maintaining a moisture content of ≤ 0.02% via Karl Fischer titration is essential for stability. High moisture levels can also accelerate the oxidation of the mercapto group during storage. Proper storage conditions, including sealed drums under nitrogen, are required to maintain this specification over time.

For large-scale operations, the consistency of moisture content directly correlates with reactor safety and yield predictability. Variability in water content can lead to exothermic deviations or incomplete conversions. Therefore, specifying tight limits on hydration is a key component of risk management in process chemistry.

Procurement and Global Supply Chain Considerations

Securing a reliable supply of specialized intermediates requires partnering with a established global manufacturer. Capacity, lead times, and regulatory documentation are key factors in vendor selection. Buyers should assess the supplier's ability to scale production from pilot plant to commercial scale without compromising quality.

NINGBO INNO PHARMCHEM CO.,LTD. stands as a premier provider of high-quality pharmaceutical intermediates, offering robust supply chains and technical support for complex molecules. By leveraging their expertise in process optimization, clients can secure favorable bulk price agreements while ensuring material consistency.

In conclusion, the technical specifications of methyl 2-(1-(mercaptomethyl)cyclopropyl)acetate are critical for the efficient production of asthma and allergy medications. Prioritizing GC purity, moisture control, and impurity profiling ensures regulatory compliance and commercial success. Partnering with a dedicated chemical manufacturer like NINGBO INNO PHARMCHEM CO.,LTD. provides the assurance needed for long-term production planning.